RagaAI Inc.

RagaAI Inc. , based in the US, develops advanced AI testing solutions aimed at transforming clinical workflows in healthcare, life sciences, and aerospace sectors. Founded in 2022 in Milpitas, US, RagaAI Inc. specializes in enterprise AI agent suites that enhance clinical operations.

The company was co-founded by Gaurav Agarwal and Mahima Shirshetty, with Agarwal serving as CEO. In January 2024, RagaAI raised USD 4. 68 million in Seed funding led by pi Ventures, with participation from other investors such as Anorak Ventures and TenOneTen Ventures, totaling USD 4. 68 million raised to date.

The company focuses on expanding its reach in healthcare and allied sectors globally. RagaAI specializes in providing enterprise healthcare AI agent suites designed to enhance clinical workflows across various sectors, including healthcare, life sciences, and aerospace. The company’s core offerings, powered by its platforms RagaAI Prism and Catalyst, include purpose-built AI agents that automate clinical operations, improve imaging informatics, and facilitate trial operations. These solutions streamline processes such as patient scheduling, eligibility checks, revenue cycle management, and clinical data evaluation, addressing inefficiencies within clinical environments.

RagaAI’s clientele comprises healthcare organizations, allergy practices, and research institutions globally, with significant deployments across the United States, Europe, and Asia, aiming to enhance patient outcomes through improved diagnostics and operational efficiency. RagaAI utilizes a subscription-based model for its products and services, offering varying pricing tiers based on the clinical solutions employed by healthcare organizations. The flagship products, RagaAI Prism and Catalyst platforms, provide advanced AI capabilities for automating clinical operations. Transactions are structured as B2B agreements, where healthcare clients purchase licenses for the AI agent suites tailored to their needs, often with ongoing support and integration services.

The financial model incorporates revenue from annual subscriptions, which include features such as real-time data analytics and compliance tools, fostering long-term partnerships within the healthcare ecosystem. In January 2024, RagaAI Inc. raised USD 4. 68 million in Seed funding led by pi Ventures, which will be utilized for research and development, innovation, and expanding its customer base.

The company plans to release new products aimed at enhancing its AI solutions for clinical operations. Additionally, RagaAI is targeting expansion into new geographic markets, including Europe and Asia, by the end of 2025, to further its reach in the healthcare sector.